# PHASE 42S — INDUSTRY INTELLIGENCE LIBRARIES — PHASE LOCK

**Phase:** 42 — Industry Intelligence Libraries (Healthcare anchor industry)
**Lock authored:** 2026-06-19
**Branch:** architecture-lane-refactor-baseline
**Lock type:** Documented attestation. This is NOT a code mechanism. The git commit
history enumerated below is the immutable record; this document is the human-readable
statement of what Phase 42's completion does and does not mean.

---

## 1. WHAT THIS LOCK MEANS

Phase 42 is **build-complete and verification-complete to a documented, bounded standard.**
All content loads as in-review reference baselines. Nothing in Phase 42 is "final" on
Advisacor's side, by design. This lock closes the phase for forward work; it does not
declare the content authoritative, customer-relied-upon-ready, or execution-capable.

This lock is consistent with the standing Phase 42 architecture:

- Two-layer attestation (Advisacor internal review = Layer 1; customer controller review,
  adaptation, and sign-off = Layer 2, where responsibility transfers).
- Three-tier governance (conformant / advised-override / fraud-block; human determination).
- Conformant spine (authoritative, cited) + adaptable joints (safe generic defaults the
  customer overwrites).
- builderNeverAuthorsContent: no builder (Cursor/Perplexity/Claude) authored contested
  professional judgment or backdated any attestation.

---

## 2. WHAT WAS BUILT (all committed, in-review baselines)

Eight content baseline modules (four generic IFRS-framework variants + four healthcare:
treatments, KPIs, disclosures, benchmarks), plus the verifier/probe infrastructure and the
resolver guard.

| Module | Content | Commit |
|---|---|---|
| 42R | Full industry-intelligence verifier (33 checks) | 3c9f26e |
| 42R | Verifier red-team probe (21 poison cases) | 4ac539c |
| 42M | Healthcare treatments (12: T1–T12) | 8417ce4 |
| 42I | Generic treatment library — us_gaap (12) | e5d3053 |
| 42I | Generic treatment library — full IASB IFRS (12) | 568d162 |
| 42I | Generic treatment library — IFRS-EU (12) | e686e74 |
| 42I | Generic treatment library — IFRS-for-SMEs (12) | 5a27f68 |
| 42N1 | Healthcare KPIs (24) | e71c06c |
| 42O | Healthcare disclosures (19) | 91e8037 |
| 42P | Healthcare reasonableness benchmarks (18 sets, 6 posture flags) | 7937cce |

Namespace: lib/intelligence/synthetic/industry/

---

## 3. RESOLVER GUARD — ENFORCED AND PROBE-PROVEN

The Treatment-11 healthcare applicabilityGuard was upgraded from metadata-only to a real,
fail-closed resolver control and proven with a dedicated poison case.

- Enforcement: buildIndustryResolution.ts — for the three T11 generic-AR-allowance topics
  (CECL / ECL / incurred-loss) against a healthcare provider entity, the resolver REFUSES to
  bind and fails closed; only a pool-level non-patient exception WITH attestation present
  permits bind; missing/malformed guard → tuple_unpopulated.
- Proof: 22nd poison case (original 21 unchanged), 4 sub-checks across all 3 topics, invoking
  the REAL resolver. Result: PROBE 22/22 PASS, 0 LEAK, 0 FINDING. Verifier and tsc green.
- Commit: ba966a5

Discipline held: the poison case was ADDED with full re-probe; no existing poison case was
swapped. First-pass green was not trusted until probe-proven.

Wiring verified (pre-lock audit): probe case 22 loads and drives the REAL resolver
(industry-resolver/index.ts buildIndustryResolution) against forbidden/allowed inputs —
not a stub or copy — and the guard functions (getTreatment11ApplicabilityGuardFailReason,
isWellFormedTreatment11ApplicabilityGuard) are invoked on the live fail-closed path, not
merely declared. All 8 content baselines confirmed loaded via dedicated loaders through the
blueprint/builder chain; industry registry declares healthcare first-class; no dangling
baseline paths.

---

## 4. VERIFICATION — COMPLETE TO A DOCUMENTED, BOUNDED STANDARD

All three healthcare content modules were citation-verified against authoritative/primary
sources via a three-party cycle: Perplexity retrieval (interpretive/figure layer) + Claude
independent web-verification (ASC/IFRS/CMS backbone + each material correction) + Janice
credentialed second-look (HFMA/MGMA/AICPA paywalled or professional-judgment items). Each
module was patched to v1.1 for the corrections found; patches were prose-only (no formula,
id, citation, metadata, posture-flag, or structural change), re-verified green, and committed.

| Module | Corrections applied | Patch commit |
|---|---|---|
| 42N1 KPIs | VER-1 (FM-2 denominator, material) · VER-2 (AR-5 5th exclusion) · VER-3 (AR-1 outpatient attribution) · VER-4 (FM-5 newborn/IPPS attribution) | 1ecdb0a |
| 42O Disclosures | VER-O-1 (ASU 2011-07 direction reversed at 4 locations, material) · VER-O-2 (Deloitte disaggregation scope) · VER-O-3 (AICPA two-guides clarifier; N/A to loaded baseline) | 8f15a73 |
| 42P Benchmarks | VER-P-1 (CAH denial-rate misattribution removed; range relabeled extrapolated/directional, material) | 237db94 |

Independently verified by Claude against primary sources (zero discrepancies in the backbone):

- US GAAP ASC paragraph backbone of 42O (disaggregation 606-10-50-5 family; variable-
  consideration constraint 606-10-32-11..16; portfolio 606-10-10-4; contract balances;
  significant judgments 606-10-50-17..21; charity care 954-605; CECL 326-20-45-1;
  contingencies 450-20/450-30).
- Effective-date table (ASU 2014-09, 2010-23, 2011-07, 2016-13/CECL) against SEC FRM + FASB.
- IFRS framework divergences against ifrs.org (IFRS 15 five-step; IAS 19 / SMEs Section 28;
  IFRS 9 ECL vs SMEs Section 11 incurred-loss; IAS 2 / IFRS 16 / IAS 16 / IFRS 10 splits).
- CMS public benchmark definitions against cms.gov (CMI, HRRP 30-day readmission, PDPM/NTA).
- The three material corrections (VER-O-1 ASU 2011-07 direction; VER-P-1 CAH attribution;
  VER-1 FM-2 denominator) independently confirmed against authoritative sources.

Evidence: PHASE_42_CITATION_VERIFICATION_REGISTER.xlsx (working audit artifact) — 101
citation rows, 83 verified/corrected-verified/stale-noted, with a Corrections-and-STALE-Log
tab recording all 8 corrections + 3 STALE flags, each with source, disposition, commit, and
controller-review mark.

### Verification remainder (bounded, low-risk, openly recorded)

- 13 us_gaap framework rows: underlying ASC paragraphs verified under VC-O/VC-M; rows marked
  conservatively, not separately re-attested.
- 3 EU endorsement-regulation rows: NEEDS-DIRECT at EUR-Lex; low-risk reference items.
- A small number of public CMS/AHRQ rows: stable government definitions, not exhaustively
  re-searched.

None of the remainder blocks the lock. All are framework cross-references or low-risk public
items, clearly labeled in the register.

---

## 5. DELIBERATELY DEFERRED — DECISIONS, NOT GAPS

These were reviewed and consciously not actioned in Phase 42:

- Three STALE benchmark refreshes (42P): Kodiak denial rate 2024→2025; Kaufman Hall
  operating margin 2024 annual→Apr-2025 monthly; HFMA MAP Award 2024 (n=14)→2026 (n=20).
  The existing ranges already bracket the newer data; figures were accurate as of cited data
  years. Tracked as register refresh candidates. For an in-review baseline the customer
  recalibrates at implementation, annual data-year drift does not warrant a module patch.
- 340B drug pricing program (Treatment T8): dual-credential-gated; NEVER Advisacor-locked
  by design. This is correct and is not a lock blocker.
- EU endorsement-regulation citations: to be confirmed directly at EUR-Lex; low risk.

---

## 6. WHAT THIS LOCK DOES NOT MEAN

- Not "final." All Phase 42 content remains in-review by design. The correct permanent
  state on Advisacor's side is in_review with blank attestation; the customer's controller
  performs Layer-2 review, adaptation, and sign-off, taking responsibility.
- Not customer-relied-upon-ready. Before any healthcare treatment is relied upon by a
  customer: E&O insurance must be in place; non-provisional patent and attorney review of the
  three-tier override / customer agreement / advisory-recommendation liability are pending
  per roadmap.
- Not execution-capable. Phase 42 is a metadata/intelligence layer. Execution capabilities
  (RM-EXEC-1 ASC 842 lease calc, RM-EXEC-2 AR/ECL engine, RM-EXEC-3 AP cutoff detector,
  RM-EXEC-4 CECL recalibration watcher) are roadmap only and were deliberately NOT built into
  the Phase 42 metadata layer.
- Not validated against live customer data. No claim is made here about behavior against
  real transactions; that is separate downstream work.

---

## 7. COMMIT RECORD (Phase 42, most recent first)

237db94  patch 42P benchmarks v1.1 (VER-P-1 + 3 STALE deferred)
8f15a73  patch 42O disclosures v1.1 (VER-O-1..VER-O-3)
1ecdb0a  patch 42N1 KPI definitions v1.1 (VER-1..VER-4)
ba966a5  enforce T11 healthcare applicabilityGuard in resolver + 22nd poison case (22/22)
7937cce  42P healthcare benchmarks (18 sets, 6 posture flags)
91e8037  42O healthcare disclosures (19)
e71c06c  42N1 healthcare KPIs (24)
5a27f68  42I IFRS-for-SMEs generic (12)
e686e74  42I IFRS-EU generic (12)
568d162  42I full-IASB-IFRS generic (12)
e5d3053  42I us_gaap generic (12)
8417ce4  42M healthcare treatments (12)
4ac539c  42R verifier red-team probe (21 poisons)
3c9f26e  42R full industry-intelligence verifier (33 checks)

---

## 8. PHASE 42 STATE

LOCKED — build-complete, verification-complete to documented bounded standard,
in-review by design, remainder openly tracked.

Next phases per roadmap (not part of this lock): 42.5 Enterprise Trust & Compliance;
product track (41 AR, 43 AP, 45 Close, 47 Tax, 49 Inventory, 51 Continuous Audit);
infrastructure (44 Twin/Sim, 46 Multi-Company, 48 Marketplace, 50 Workforce); capstone 60 GA.
